Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Access to genetic counseling and testing are an important part of cancer control

Ten years after the identification of the first breast cancer susceptibility genes so few high-risk minority women have received genetic counseling or testing that the standard methods of calculating risk have not been validated in these groups and the results of genetic testing can still produce surprises.

18 Oct 2005

Data supports use of personal and family history of breast cancer, ovarian cancer, or both in making clinical decisions

African American women at high-risk of breast cancer have genetic mutations that would make genetic testing feasible, according to a study in the October 19 issue of JAMA: The Journal of the American Medical Association.

18 Oct 2005

Removing metastatic disease from the diaphragm significantly increases survival rates in ovarian cancer patients

In a retrospective study looking back at a decade of surgeries, Mayo Clinic Cancer Center researchers have determined that surgery to remove metastatic disease from the diaphragm, in conjunction with other procedures to remove the primary diseased tissue in ovarian cancer patients, significantly increases survival rates.

12 Oct 2005

Common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer

A relatively common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer, and give cancer cells a growth advantage, according to a study in the October 5 issue of JAMA: The Journal of the American Medical Association.

4 Oct 2005

Discovery establishes a role for the gene Rsf-1 in ovarian cancer

Johns Hopkins Kimmel Cancer Center researchers have linked alterations in a gene, called Rsf-1, to the most deadly ovarian cancers. The scientists say the discovery is the first to establish a role for the gene in ovarian cancer and may lead to a test that can predict, early on, which patients will develop aggressive disease.

3 Oct 2005

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

...a discovery that could pave the way for more effective cancer treatments.

27 Sep 2005

Mutations in receptor tyrosine kinases provide potential for highly-targeted cancer therapies

Scientists from J. Craig Venter Institute, Ludwig Institute for Cancer Research, and The Johns Hopkins University School of Medicine identified three novel mutations in two receptor tyrosine kinases in glioblastoma tumors using high throughput sequencing.

26 Sep 2005

State-of-the-art treatment program increases survival from the aggressive uterine papillary serous carcinoma

"Our study defines a standard of care for this aggressive and growing form of uterine cancer," said Schwartz, who is also assistant chief of obstetrics and gynecology at Yale-New Haven Hospital. The procedure more accurately determines the complete stage and appropriate treatment and reduces the recurrence of the cancer.

26 Sep 2005

Simple, fast and effective method of detecting a large number of patients at high risk for hereditary breast/ovarian cancer

One in five women diagnosed with breast or ovarian cancer who seek mammography have a family history of cancer that suggests they may harbor known cancer-causing gene mutations.

26 Sep 2005

Questionnaire helps identify women who have inherited genetic mutations that increase their risk for breast or ovarian cancer

A simplified way for patients to report and update their family medical histories could help identify women who have inherited genetic mutations that increase their risk for breast or ovarian cancer.

26 Sep 2005

Increased ovarian cancer risk not linked to cancer family history

Women with a strong family history of breast cancer but who don't have breast cancer genetic mutations can now be reassured that they are not at increased risk for ovarian cancer, according to a new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC).

21 Sep 2005

Translation elongation factor eEF1A2 is is a potential oncogene that is overexpressed in two-thirds of breast tumors

The tissue-specific elongation factor eEF1A2 might be an oncoprotein involved in breast cancer.

12 Sep 2005

Testing for specific breast cancer genes unadvisable if no family history of disease exists

According to the Preventive Services Task Force in the U.S., routine testing for mutations in the BRCA1 and BRCA2 genes, which have been linked to breast and ovarian cancer, are not advised unless women have a family history of the disease.

7 Sep 2005

New recommendations for screening for BRCA1 and BRCA2 gene mutations

The United States Preventive Services Task Force issues new recommendations for screening for BRCA1 and BRCA2 gene mutations in the Sept. 6, 2005, issue of Annals of Internal Medicine.

5 Sep 2005

Scientists help narrow the search for BRCA1 carriers

Cancer Research UK scientists have identified a new test which may help narrow the search for breast cancer patients likely to carry the faulty BRCA1 gene.

30 Aug 2005

Appropriate tests need to be done earlier for ovarian cancer

A new study to be published in the journal CANCER in October has found that many women diagnosed with ovarian cancer actually complained of symptoms of the disease at least four months before they were diagnosed.

23 Aug 2005

Discovery of a potential oncogene in ovarian cancer

Researchers at The University of Texas M. D. Anderson Cancer Center report they have discovered a potential oncogene in ovarian cancer, which is the leading cause of gynecological cancer death in U.S. women.

22 Aug 2005

Early clinical signs of ovarian cancer

Many women diagnosed with ovarian cancer actually complained of symptoms of the disease at least four months before they were diagnosed, according to a new study to be published in the October 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

22 Aug 2005

Enzyme called matriptase, when left to its own devices, can cause cance

Scientists at the National Institute of Dental and Craniofacial Research (NIDCR) and colleagues report in animal studies that a single, scissor-like enzyme called matriptase, when left to its own devices, can cause cancer.

16 Aug 2005

Researchers have found a signal that could lead to earlier detection and treatment of ovarian cancer

The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.

13 Aug 2005

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Access to genetic counseling and testing are an important part of cancer control

Data supports use of personal and family history of breast cancer, ovarian cancer, or both in making clinical decisions

Removing metastatic disease from the diaphragm significantly increases survival rates in ovarian cancer patients

Common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer

Discovery establishes a role for the gene Rsf-1 in ovarian cancer

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

Mutations in receptor tyrosine kinases provide potential for highly-targeted cancer therapies

State-of-the-art treatment program increases survival from the aggressive uterine papillary serous carcinoma

Simple, fast and effective method of detecting a large number of patients at high risk for hereditary breast/ovarian cancer

Questionnaire helps identify women who have inherited genetic mutations that increase their risk for breast or ovarian cancer

Increased ovarian cancer risk not linked to cancer family history

Translation elongation factor eEF1A2 is is a potential oncogene that is overexpressed in two-thirds of breast tumors

Testing for specific breast cancer genes unadvisable if no family history of disease exists

New recommendations for screening for BRCA1 and BRCA2 gene mutations

Scientists help narrow the search for BRCA1 carriers

Appropriate tests need to be done earlier for ovarian cancer

Discovery of a potential oncogene in ovarian cancer

Early clinical signs of ovarian cancer

Enzyme called matriptase, when left to its own devices, can cause cance

Researchers have found a signal that could lead to earlier detection and treatment of ovarian cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in